122 related articles for article (PubMed ID: 37619407)
1. Stepwise progression of invasive mucinous adenocarcinoma based on radiological and biological characteristics.
Goto E; Takamochi K; Kishikawa S; Hayashi T; Ueda T; Hattori A; Fukui M; Matsunaga T; Suzuki K;
Lung Cancer; 2023 Oct; 184():107348. PubMed ID: 37619407
[TBL] [Abstract][Full Text] [Related]
2. Comparing clinicopathological features and prognosis of primary pulmonary invasive mucinous adenocarcinoma based on computed tomography findings.
Nie K; Nie W; Zhang YX; Yu H
Cancer Imaging; 2019 Jul; 19(1):47. PubMed ID: 31292000
[TBL] [Abstract][Full Text] [Related]
3. Lepidic predominant adenocarcinoma and invasive mucinous adenocarcinoma of the lung exhibit specific mucin expression in relation with oncogenic drivers.
Duruisseaux M; Antoine M; Rabbe N; Rodenas A; Mc Leer-Florin A; Lacave R; Poulot V; Duchêne B; Van Seuningen I; Cadranel J; Wislez M
Lung Cancer; 2017 Jul; 109():92-100. PubMed ID: 28577958
[TBL] [Abstract][Full Text] [Related]
4. Primary Invasive Mucinous Adenocarcinoma of the Lung: Prognostic Value of CT Imaging Features Combined with Clinical Factors.
Wang T; Yang Y; Liu X; Deng J; Wu J; Hou L; Wu C; She Y; Sun X; Xie D; Chen C
Korean J Radiol; 2021 Apr; 22(4):652-662. PubMed ID: 33236544
[TBL] [Abstract][Full Text] [Related]
5. Diffuse expression of MUC6 defines a distinct clinicopathological subset of pulmonary invasive mucinous adenocarcinoma.
Kishikawa S; Hayashi T; Saito T; Takamochi K; Kohsaka S; Sano K; Sasahara N; Sasa K; Kurihara T; Hara K; Suehara Y; Takahashi F; Suzuki K; Yao T
Mod Pathol; 2021 Apr; 34(4):786-797. PubMed ID: 33024306
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the immunotherapy efficacy between invasive mucinous and non-mucinous adenocarcinoma in advanced lung cancer patients with KRAS mutation: a retrospective study.
Xu M; Hao Y; Zhou H; Shi Z; Si J; Song Z
Med Oncol; 2023 Jun; 40(7):198. PubMed ID: 37294384
[TBL] [Abstract][Full Text] [Related]
7. [Advanced Pneumonic-type Lung Carcinoma: A Retrospective Study of Clinical-radiological-pathological Characteristics with Survival Analysis in A Single Chinese Hospital].
Liu Y; Li J; Wang S; Chen M; Zhao J; Jiang D; Zhong W; Xu Y; Wang M
Zhongguo Fei Ai Za Zhi; 2019 Jun; 22(6):329-335. PubMed ID: 31196365
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung.
Ueda D; Ito M; Tsutani Y; Giménez-Capitán A; Román-Lladó R; Pérez-Rosado A; Aguado C; Kushitani K; Miyata Y; Arihiro K; Molina-Vila MA; Rosell R; Takeshima Y; Okada M
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3709-3718. PubMed ID: 33796913
[TBL] [Abstract][Full Text] [Related]
9. Invasive mucinous adenocarcinoma of the lung: clinicopathological features,
Sun X; Zeng B; Tan X; Chen Z; Pan X; Jiang L
Ann Nucl Med; 2023 Mar; 37(3):198-207. PubMed ID: 36538165
[TBL] [Abstract][Full Text] [Related]
10. Pneumonic-type invasive mucinous adenocarcinoma and infectious pneumonia: clinical and CT imaging analysis from multiple centers.
Zhang S; Yu X; Huang Y; Nie P; Deng Y; Mao N; Li S; Zhu B; Wang L; Wang B; Wang X
BMC Pulm Med; 2022 Dec; 22(1):460. PubMed ID: 36461012
[TBL] [Abstract][Full Text] [Related]
11. Correlation exploration among CT imaging, pathology and genotype of pulmonary ground-glass opacity.
Cai Y; Chen T; Zhang S; Tan M; Wang J
J Cell Mol Med; 2023 Jul; 27(14):2021-2031. PubMed ID: 37340599
[TBL] [Abstract][Full Text] [Related]
12. Radiological and clinical features of screening-detected pulmonary invasive mucinous adenocarcinoma.
Kim DH; Bae SY; Na KJ; Park S; Park IK; Kang CH; Kim YT
Interact Cardiovasc Thorac Surg; 2022 Jan; 34(2):229-235. PubMed ID: 34570199
[TBL] [Abstract][Full Text] [Related]
13. NRG1 fusion in a French cohort of invasive mucinous lung adenocarcinoma.
Duruisseaux M; McLeer-Florin A; Antoine M; Alavizadeh S; Poulot V; Lacave R; Rabbe N; Cadranel J; Wislez M
Cancer Med; 2016 Dec; 5(12):3579-3585. PubMed ID: 27770508
[TBL] [Abstract][Full Text] [Related]
14. Pathological features and prognostic implications of ground-glass opacity components on computed tomography for clinical stage I lung adenocarcinoma.
Katsumata S; Aokage K; Ishii G; Hoshino H; Suzuki J; Miyoshi T; Tane K; Samejima J; Tsuboi M
Surg Today; 2021 Jul; 51(7):1188-1202. PubMed ID: 33745094
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary invasive mucinous adenocarcinoma.
Chang WC; Zhang YZ; Nicholson AG
Histopathology; 2024 Jan; 84(1):18-31. PubMed ID: 37867404
[TBL] [Abstract][Full Text] [Related]
16. Relation between thin-section computed tomography and clinical findings of mucinous adenocarcinoma.
Watanabe H; Saito H; Yokose T; Sakuma Y; Murakami S; Kondo T; Oshita F; Ito H; Nakayama H; Yamada K; Iwazaki M
Ann Thorac Surg; 2015 Mar; 99(3):975-81. PubMed ID: 25624054
[TBL] [Abstract][Full Text] [Related]
17. EGFR L858R mutation is associated with lung adenocarcinoma patients with dominant ground-glass opacity.
Yang Y; Yang Y; Zhou X; Song X; Liu M; He W; Wang H; Wu C; Fei K; Jiang G
Lung Cancer; 2015 Mar; 87(3):272-7. PubMed ID: 25582278
[TBL] [Abstract][Full Text] [Related]
18. Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma.
Miyoshi T; Aokage K; Katsumata S; Tane K; Ishii G; Tsuboi M
Ann Thorac Surg; 2019 Jul; 108(1):249-255. PubMed ID: 30876742
[TBL] [Abstract][Full Text] [Related]
19. Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation.
Kadota K; Yeh YC; D'Angelo SP; Moreira AL; Kuk D; Sima CS; Riely GJ; Arcila ME; Kris MG; Rusch VW; Adusumilli PS; Travis WD
Am J Surg Pathol; 2014 Aug; 38(8):1118-27. PubMed ID: 25029118
[TBL] [Abstract][Full Text] [Related]
20. Clinical, pathological and thin-section CT features of persistent multiple ground-glass opacity nodules: comparison with solitary ground-glass opacity nodule.
Kim TJ; Goo JM; Lee KW; Park CM; Lee HJ
Lung Cancer; 2009 May; 64(2):171-8. PubMed ID: 18799230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]